2013, Number 4
<< Back Next >>
MEDICC Review 2013; 15 (4)
Frequency and antimicrobial sensitivity of Ureaplasma urealyticum and Mycoplasma hominis in patients with vaginal discharge
Díaz L, Cabrera LE, Fernández T, Ibáñez I, Torres Y, Obregón Y, Rivero Y
Language: English
References: 26
Page: 45-47
PDF size: 163.00 Kb.
ABSTRACT
Determination of antimicrobial sensitivity helps establish adequate treatment and avoids future genital tract diseases in women of fertile age. In Cuba, prevalence of mycoplasma in patients with vaginal discharge is unknown. The objective of this research was to determine frequency and antimicrobial sensitivity of
Ureaplasma urealyticum and
Mycoplasma hominis in women with vaginal discharge through analysis of laboratory data from vaginal smears from 255 patients referred to the Municipal Hygiene and Epidemiology Center in Güines, Mayabeque Province, Cuba. Mycoplasma System Plus (Italy) was used for detection, identification, count and sensitivity testing. The finding of mycoplasmas in almost two thirds of specimens examined suggests that the sexually active female population should be screened for these bacteria and that barrier contraception methods should be promoted to decrease their spread and prevent longterm sequelae. Such updating of local patterns of antimicrobial resistance supports decision making for best treatment options in patients with these infections. Our results should help clinicians in our area choose an antibiotic, and also confirm the utility of Mycoplasma System Plus for mycoplasma research in resource-scarce settings, to benefit individual and population health.
REFERENCES
Taylor-Robinson D, Jensen JS, Svenstrup H, Stacey CM. Diffi culties experienced in defi ning the microbial cause of pelvic infl ammatory disease. Int J STD AIDS. 2012 Jan;23(1):18–24.
Le Roy C, Le Hen I, Clerc M, Arfel V, Normandin F, Bébéar C, et al. The fi rst performance report for the Bio-Rad Dx CT/NG/MG assay for simultaneous detection of Chlamydia trachomatis, Neisseria gonorrhoeae and Mycoplasma genitalium in urogenital samples. J Microbiol Methods. 2012 Jun;89(3):193–7.
Rivera JA, Cedillo ML, Vega M. Micoplasmas y su importancia médica. Rev Biomed. 2001;12(4):262–71. Spanish.
Kataoka S, Yamada T, Chou K, Nishida R, Morikawa M, Minami M, et al. Association between preterm birth and vaginal colonization by mycoplasmas in early pregnancy. J Clin Microbiol. 2006 Jan;44(1):51–5.
Rivera JA, Centeno M, Santellan OM, Rodríguez NM. Prevalencia de Ureaplasma urealyticum en mujeres. Rev Mex Patol Clin. 2004;51(1):33–6. Spanish.
Ramírez C, Casanova G, Menoca G, Ortiz F, Ahued R. Prevalencia de la infección cervicovaginal por Mycoplasma hominis y Ureaplasma urealyticum en pacientes ginecológicas del Instituto Nacional de Perinatología. Enf Inf Microbiol. 2004;24(1):107–11. Spanish.
Fagundo R, Sánchez A, Jáuregui J. Comportamiento antimicrobiano de aislamientos clínicos de Mycoplasma hominis y Ureaplasma urealyticum así como la evolución de su resistencia en un periodo de cinco años. Labciencia. 2006;14(2):75–9. Spanish.
Zuo CX, Huang JH, Chen J, Lu JY, Xiang YP. [Female urogenital mycoplasma infection and drug sensitivity status in Changsha]. Nan Fang Yi Ke Da Xue Xue Bao. 2006 Jun;26(6):831–6. Chinese.
Karabay O, Topcuoglu A, Kocoglu E, Gurel S, Gurel H, Ince NK. Prevalence and antibiotic susceptibility of genital Mycoplasma hominis and Ureaplasma urealyticum in a university hospital in Turkey. Clin Exp Obstet Gynecol. 2006;33(1):36–8.
Ortiz Rodríguez CE, Hechavarría Calderín CE, Ley Ng M, Álvarez Medina G, Hernández Ortiz Y. Estudio de Chlamydia trachomatis, Ureaplasma urealyticum y Mycoplasma hominis en pacientes infértiles y abortadoras habituales. Rev Cuba Obstet Ginecol. 2010 Oct–Dec;36(4):42–7. Spanish.
Fernández Molina C, Zamora Martínez Y, Rodríguez Preval N, Rodríguez González I, Berdasquera Corcho D, Ortega González LM. Diagnóstico de Mycoplasma hominis, Ureaplasma parvum y Ureaplasma urealyticum en pacientes con vaginosis bacteriana. Rev Cubana Med Trop. 2007;59(2):82–6. Spanish.
Reyna Figueroa J, Villeda Gabriel G, Ortiz Ibarra FG, Morales Méndez I, Flores Medina S. Detección de micoplasmas genitales y su sensibilidad antimicrobiana mediante una prueba rápida en muestras clínicas de parejas mexicanas con infertilidad. Enf Inf Microbiol. 2009;29(2):54–8. Spanish.
Liofi lchem Bacteriology Products. Mycoplasma System Plus System for the detection, semiquantitative determination and susceptibility test of urogenital mycoplasmas [Internet]. Teramo (IT): Liofi lchem; 2012 [cited 2013 Jul 20]. 40 p. Available from: http://www.liofi lchem.net/login.area/pd/ database_pi/72592_PI.pdf.
Solís-Martínez R, Vázquez-Castillo T, Celis S, Hernández-Callejas L. Susceptibilidad de Mycoplasma hominis y Ureaplasma urealyticum ante diferentes antibióticos. Rev Med UV. 2006 Jul– Dec;6(2):11–7. Spanish.
Castellano-González M, Ginestre-Pérez M, Perozo- Mena A, Alaña F, Fernández-Bravo M, Rincón Villalobos G. [Vaginal colonization by genital mycoplasmas in pregnant and non-pregnant women]. Invest Clin. 2007 Dec;48(4):419–29. Spanish.
Agbakoba NR, Adetosoye AI, Adewole IF. Presence of mycoplasma and ureaplasma species in the vagina of women of reproductive age. West Afr J Med. 2007 Jan–Mar;26(1):28–31.
González-Pedraza A, Ortiz C, Dávila R, Valencia CM. Infecciones cervicovaginales más frecuentes; prevalencia y factores de riesgo. Rev Cubana Obstet Ginecol. 2007;33(2):15–9. Spanish.
Vázquez F, Otero L, Ordás J, Junquera ML, Varela JA. Actualización en infecciones de transmisión sexual: epidemiología, diagnóstico y tratamiento. Enf Infecc Microbiol Clin. 2004;22(7):392–411. Spanish.
Martin IM, Hoffmann S, Ison CA; ESSTI Network. European Surveillance of Sexually Transmitted Infections (ESSTI): the fi rst combined antimicrobial susceptibility data for Neisseria gonorrhoeae in Western Europe. J Antimicrob Chemother. 2006 Sep;58(3):587–93.
Wagenlehner FM, Wullt B, Perletti G. Antimicrobials in urogenital infections. Int J Antimicrob Agents. 2011 Dec;38 Suppl:3–10.
Krausse R, Schubert S. In-vitro activities of tetracyclines, macrolides, fl uoroquinolones and clindamycin against Mycoplasma hominis and Ureaplasma spp. isolated in Germany over 20 years. Clin Microbiol Infect. 2010 Nov;16(11):1649–55.
Kechagia N, Bersimis S, Chatzipanagiotou S. Incidence and antimicrobial susceptibilities of genital mycoplasmas in outpatient women with clinical vaginitis in Athens, Greece. J Antimicrob Chemother. 2008 Jul;62(1):122–5.
Wang Y, Yang WB, Yuan HY, Zhang QX, Zhu XY. Analysis of the infection status and the drug resistance of mycoplasma and chlamydiae in genitourinary tracts of children with suspected nongonococcal urethritis. Zhonghua Er Ke Za Zhi. 2009 Jan;47(1):62–4. Chinese.
Ortega Figueroa LM, Álvarez Pineda AB, Águila Nogueira Y, Viera Hernández MI. Detección de infección por Mycoplasma en las gestantes con riesgo de parto pretérmino. Rev Cuba Ginecol Obstet. 2012;38(2):161–9. Spanish.
Fagundo Sierra R, Sánchez Saínz A, Pérez Jáuregui J. Resistencia in vitro de aislamientos clínicos de Mycoplasma hominis y Ureaplasma urealyticum en México. Bioquímica. 2006 Oct– Dec;31(4):124–31. Spanish.
Orellana Miguel MA, Gómez–Lus ML. ¿Qué tratamiento empírico es el más adecuado en pacientes con uretritis? Rev Esp Quimioter. 2011 Sep;24(3):136–42. Spanish.